Beitrag von Paul Gavin

🔔IPO ALERT!🔔 Valiant Laboratories Ltd. is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company focusing on manufacturing Paracetamol. Paracetamol is recommended as the first-line therapy in pain conditions by the World Health Organization. Here’s why we suggest Subscribing to this issue: https://lnkd.in/dffd7UjW Follow StoxBox for more insightful recommendations. Check the complete recommendation on the StoxBox website. #DiversePortfolio #StoxBox #StoxBoxIndia #IPOAlert #SubscribeIPO #Subscribe #IPOInsights #InvestWisely #StoxBoxRecommendations  #IPORecommendation #StoxBoxResearch #StockMarket #ValiantLaboratoriesLtd

Great News for Barentz! 🙌 The global leading distributer of life science ingredients has recently accounted its grand opening of a new pharmaceutical development center. With the new opening in Mexico city, Barentz continues to show its commitment to the pharmaceutical and nutraceutical sectors. The facility will focus on a range of key formulation areas, including both oral solids and liquid dosage forms. I look forward to watching the developments Mike McKenna👏 #pharmaceutical #development #lifescience #Barentz #linkedinpost

How the Pharmaceutical Supply Chain Works The first step in the pharma supply chain is for the pharmaceutical company to either develop or source the two building blocks of a drug product: Active Pharmaceutical Ingredients (APIs) and excipients. APIs: The active ingredient in drugs that produces the intended health effect, manufactured using a range of synthetic and biological raw materials. Excipients: Includes any substance other than the API that helps deliver the medication into the patient’s system. They are chemically inactive, allow the medicine to remain stable, and control the absorption of the drug. After developing APIs and excipients, the pharma company moves on to the manufacturing phase. This aspect of the supply chain falls under one of the following four manufacturing categories: Biologics: Vaccines, blood, allergens, genes, and tissues Prescribed Drugs: Opioids, benzodiazepines, and stimulants Over-the-Counter (OTC) Medicines: Vitamins, minerals, supplements, common cough and cold drugs, and dermatology products Raw Materials and Bulk Pharmaceuticals: Chemical compounds and APIs The manufacturer can apply for a patent if the medicine or drug is a new product. In the United States and European Union (EU), a drug patent lasts 20 years from the filing date. Once the patent expires, other pharma companies are free to manufacture and distribute the drug product, leading to a multitude of supply chain channels being involved. After the drug product is manufactured, a wholesaler purchases the medications directly from the manufacturer. This then stipulates that the wholesaler pass the pharmaceutical products to a storage provider/distributor for logistics handling. For the endpoint of the pharmaceutical supply chain, the drug product can get to the patient in three different ways: Hospital/clinic Pharmacy & retail Mail order Pharmaceutical Supply Chain #supplychainmanagement #pharmaceuticals #manufacturing #logistics #retail #health

Did you know that the risk of nitrosamine contamination is higher in drug products than previously thought? With new legislation on the horizon, an effective nitrosamine mitigation strategy requiring formulation, technical and regulatory expertise is crucial to succeed in this complex landscape. In a NEW expert interview with @Drug-Discovery&Development, our esteemed colleague Anne-Cécile Bayne, Global Science and Innovation Lead for Pharma and Medical Nutrition dsm-firmenich, examines this latest research and explores potential nitrosamine mitigation strategies. https://lnkd.in/eDewTgF6   #nitrosamines #pharmaceuticals #formulation #excipients #drugproduct #antioxidant #inhibition #DSMPharma